SLGL - Sol Gel Technologies Ltd logo

SLGL

Sol Gel Technologies Ltd

Sol-Gel Technologies develops and commercializes topical dermatological drugs for severe skin conditions, offering products like Twyneo for acne and Epsolay for rosacea, while advancing other treatments in clinical trials, targeting diverse international markets.

โš•๏ธ Healthcare NASDAQ Listed 2018 $ USD
$1,000 invested 5 years ago โ†’$730today

Score Overview

1 Year
Score
Net Growth82.93%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth-4.76%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score3.6
Net Growth-132.47%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth-40.95%
Rev Trend40%
Revenue Consistencyโ€”
All Time
Score
Net Growth96.75%
Net Trend63%
Net Income Consistency
Rev Growth143x
Rev Trend50%
Revenue Consistency

See the full market ranking โ†’

Sol Gel Technologies Ltd fundamental performance

Between 2020 and 2025, revenue grew from $ 8M to $ 19M and net income went from -$ 27M to -$ 6M. Revenue increased in 2 of those 5 years; net income in 3.

Sol Gel Technologies Ltd currently holds a 5-year HDB Score of 3.6 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 71.50โ€”
1 Year2025-08-12
$ 15.25368.85%
5 Years2021-08-12
$ 97.90-26.97%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 18M-$ 1M
2025$ 19M-$ 6M$ 23M
2024$ 11M-$ 10M$ 23M
2023$ 1M-$ 27M$ 37M
2022$ 3M-$ 14M$ 33M
2021$ 31M$ 3M$ 43M
2020$ 8M-$ 27M$ 50M
2019$ 22M-$ 24M$ 50M
IPO2018$ 129K-$ 32M$ 62M

Explore beyond SLGL

You're looking at Sol Gel Technologies Ltd. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies